Xiwen Ma

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

Wenqian Zhang, Ying Yu, Falk Hertwig et al. · Genome Biology · 2015 · 429 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo et al. · The Lancet Haematology · 2020 · 337 citations · Full text

Medicine, Hematology, Oncology +11

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

Sheng-Bin Peng, James R. Henry, Michael D. Kaufman et al. · Cancer Cell · 2015 · 309 citations · Full text

Medicine, Cancer Biology, Oncology +16

Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

Ying Chen, Jeremy McGee, Xian‐Ming Chen et al. · PLoS ONE · 2014 · 136 citations · Full text

Life Sciences, Genetics, Oncology +17

Whole-Genome Sequencing of Asian Lung Cancers: Second-Hand Smoke Unlikely to Be Responsible for Higher Incidence of Lung Cancer among Asian Never-Smokers

Vidhya G. Krishnan, Philip J. Ebert, Jason C. Ting et al. · Cancer Research · 2014 · 43 citations · Full text

Medicine, Genetics, Oncology +17